Zydus Cadila seeks govt nod to start Phase-III clinical trials of Covid-19 vaccine

Drug firm Zydus Cadila on Thursday said its vaccine against Covid-19, 'ZyCoV-D', has been found to be safe and immunogenic in the Phase I/II clinical trials, and the company is seeking regulatory approval to commence Phase-III trials.